News and Stories About precision medicine

Editor’s note: Originally published in February 2021, we’ve updated this article to include the exciting news that the first drug […]
READ MORE

The 2021 Gastrointestinal (GI) Cancers Symposium recently brought together oncologists, researchers, patients and patient advocates, including the Pancreatic Cancer Action […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today’s article describes the complex and changing landscape of clinical […]
READ MORE

Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

If you have a first-degree relative (parent, child or sibling) who was diagnosed with pancreatic cancer, you may have an […]
READ MORE

Editor’s note: It’s Rare Cancer Day, so we thought we’d take the opportunity to talk about how rare pancreatic cancer […]
READ MORE

In its latest guidelines for the treatment of patients with metastatic pancreatic cancer, the American Society of Clinical Oncology (ASCO) […]
READ MORE

Editor’s note: “Jeopardy!” host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy […]
READ MORE

A drug that received unprecedented approval in the U.S. three years ago is now available for even more patients. In […]
READ MORE

Editor’s note: Earlier this year, we featured Steven Merlin’s amazing dedication as a Pancreatic Cancer Action Network (PanCAN) volunteer and […]
READ MORE

You are your own best advocate. If you’ve been diagnosed with a disease like pancreatic cancer, it’s important to get […]
READ MORE

The theme for the 2020 American Society of Clinical Oncology’s (ASCO) Annual Meeting was “Unite & Conquer: Accelerating Progress Together.” […]
READ MORE

About one in four pancreatic cancer patients have changes in their tumor that suggest certain treatments may work particularly well […]
READ MORE

A recent paper published in the prestigious journal Lancet Oncology showed that the Pancreatic Cancer Action Network’s (PanCAN) Know Your […]
READ MORE

Pancreatic Cancer Action Network and Perthera Study in Lancet Oncology Underscores the Urgent Need for Every Pancreatic Cancer Patient to […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® precision medicine service can help pancreatic cancer patients live longer. Know […]
READ MORE

Stage IV pancreatic cancer survivor Ken Harding was no longer having great results after nine months on standard chemotherapy.  But […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: Sadly, Gina passed away in January 2021. We are so grateful she shared her story to inspire and […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today we share the experience of a stage IV pancreatic […]
READ MORE

The Food and Drug Administration (FDA) recently approved the treatment Lynparza® (olaparib) for use in a group of pancreatic cancer […]
READ MORE

Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

Editor’s note: Mary Fox passed away in January 2020. We are grateful she allowed her story to be shared. In […]
READ MORE

People with pancreatic cancer and a specific type of change – or mutation – in their DNA live longer when […]
READ MORE

Editor’s note: We are deeply saddened to share that Adam Deal died of pancreatic cancer in December 2020. His advocacy […]
READ MORE

When the Pancreatic Cancer Action Network (PanCAN) launched its Know Your Tumor® precision medicine service, molecular profiling was offered for […]
READ MORE

It’s Cancer Immunotherapy Month. Here, we discuss immunotherapy and pancreatic cancer.

Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE

This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE

The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE

An imaging test may find a tumor on the pancreas, which could be benign (non-cancerous) or malignant (cancerous). Getting a […]
READ MORE

Editor’s note: The National Comprehensive Cancer Network (NCCN), which sets guidelines for the treatment and management of pancreatic adenocarcinoma (the […]
READ MORE

“I’ve been attending the American Association for Cancer Research (AACR) annual meetings for several years, and this year’s conference was […]
READ MORE

About 10 percent of pancreatic cancer cases are thought to be hereditary – caused by an inherited genetic alteration that […]
READ MORE

The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE

When Allison Perlis of Potomac, Md., first began experiencing symptoms of pancreatic cancer in early 2017, she dismissed them as […]
READ MORE

Around Christmas 2016, Karen Kiernan was enjoying the holidays at her family home in Truckee, Calif., when she began to […]
READ MORE

A recently published article on TIME.com highlights important steps patients should take after a cancer diagnosis and mentions that the […]
READ MORE

Last week, Jenny Isaacson, vice president of strategic partnerships and projects at the Pancreatic Cancer Action Network (PanCAN), championed cross-sector […]
READ MORE

Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE

Elise Tedeschi was shocked when she was diagnosed with stage IV pancreatic cancer. She was only 42 years old, enjoying […]
READ MORE

The U.S. Food and Drug Administration (FDA) approved Vitrakvi® (larotrectinib) today for the treatment of any locally advanced or metastatic solid tumor, […]
READ MORE

The Atlantic’s People v. Cancer event took place Nov. 14, 2018, in New York City. The event featured a stellar […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) offers an Ask PanCAN Patient Services series to provide helpful tips and information about […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) has now delivered personalized molecular profiling reports to 1,000 pancreatic cancer patients through its […]
READ MORE

“I was 7 years old when my dad’s mom, Gertrud, was diagnosed with breast cancer,” began Pamela Munster, MD, a […]
READ MORE

When doctors told David Watson of Santa Monica, Calif., that he had type 2 diabetes in November 2016, he couldn’t […]
READ MORE

A biomarker is a substance found in the body that can be measured. The amount of a biomarker may vary […]
READ MORE

The fitting theme for this year’s Pancreatic Cancer Action Network (PanCAN) Annual Scientific Summit, occurring Aug. 23-26, 2018, in San […]
READ MORE

Before Allison Lippman of Dallas met her now-husband, she was not convinced she wanted to date anyone. “I was turning […]
READ MORE

Editor’s note, March 2, 2020: Results published in Lancet Oncology from the Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® […]
READ MORE

Cancer immunotherapy involves efforts to harness the patient’s own immune system to recognize and attack tumor cells. To date, the […]
READ MORE

Published today in the esteemed Clinical Cancer Research, a journal of the American Association for Cancer Research, the Pancreatic Cancer […]
READ MORE

With the Identification of Six Genetic Mutations, Authors Urge Genetic Testing for All Pancreatic Cancer Patients – Not Only Those […]
READ MORE

A pancreatic cancer diagnosis can lead to a lot of questions, including how to choose a healthcare team, deciding on […]
READ MORE

Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE

It is important to know all your treatment options at every stage of your pancreatic cancer diagnosis. Here are five […]
READ MORE

The American Society of Clinical Oncology (ASCO) has updated their treatment guidelines for patients with metastatic pancreatic cancer, or disease […]
READ MORE

Editor’s note: Below we describe recent updates to the National Comprehensive Cancer Network’s (NCCN) guidelines for the treatment and management […]
READ MORE

Did you know that DNA gets its own day? It’s today! National DNA Day has been celebrated since 2003, when […]
READ MORE

The theme for this year’s American Association for Cancer Research (AACR) Annual Meeting, which took place earlier this week in […]
READ MORE

In a recent Forbes article, “She Was Given Three Years To Live. So She Transformed Cancer Research,” Pancreatic Cancer Action […]
READ MORE

Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE

About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation […]
READ MORE

“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE

Editor’s note: This article is another installment in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE

At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE

Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE

Akshay Mehta, MD, was in the middle of performing an orthopedic surgery when his first pancreatic cancer symptom arose. “I […]
READ MORE

Among the many genetic mutations and molecular alterations that can be found in pancreatic tumors, there are four that are […]
READ MORE

Pancreatic cancer is difficult to treat. There are a few standard treatments, but there are additional options that we encourage […]
READ MORE

“Let’s face it: The pancreas is a behind-the-scenes organ most of us don’t know – or think – much about. […]
READ MORE

The American Association for Cancer Research (AACR) released its annual Cancer Progress Report earlier this week. “Research continues to be […]
READ MORE

The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE

The cleverly named The Cancer Genome Atlas project – abbreviated TCGA, in homage to the four base pairs that make […]
READ MORE

Every pancreatic tumor is different. The Pancreatic Cancer Action Network strongly recommends molecular profiling of your tumor to help determine […]
READ MORE

Pancreatic Cancer Action Network invests in precision medicine and early detection to change outcomes for the world’s toughest cancer MANHATTAN […]
READ MORE

Editor’s note: Keytruda was the first cancer drug approved to treat any solid tumor – anywhere in the body – […]
READ MORE

May was a busy month for pancreatic cancer precision medicine developments. Every pancreatic tumor is different. The Pancreatic Cancer Action […]
READ MORE

Editor’s note: Sadly, Josephine Scivoli passed away in November 2019. We are grateful she allowed her story to be shared. Josephine […]
READ MORE

The American Association for Cancer Research (AACR) is spearheading a large-scale molecular profiling effort called Project Genomics Evidence Neoplasia Information […]
READ MORE

Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE

For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE

The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE

Making treatment decisions may be overwhelming. We want to make sure you have the information you need, every step of […]
READ MORE

Revolutionary Clinical Trial Initiative Focuses On Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients […]
READ MORE

Dr. Andrew E. Hendifar, the medical oncology lead for the gastrointestinal disease research group at Cedars-Sinai Medical Center, champions progress […]
READ MORE

We’ve learned a lot about pancreatic cancer in recent years, and we now know that every patient’s cancer is different […]
READ MORE